This book offers a unique perspective on the basal ganglia and parkinson's disease from an electrophysiology point of view. I've read countless articles regarding neuromodulation for parkinson's disease and a textbook on microelectrode recording for deep brain stimulation. However, this book provides a unique set of information not commonly found elsewhere. The devil is in the details, and this book uncovers the details regarding all the major nuclei in the basal ganglia.
The book is highly technical and abstract. The author has a distinctive tone in his writing, often striving to be pithy. Unfortunately, he fails. It only reads as an unnecessary distraction. Furthermore, the author attempts to compact rigorous technical facts into mere sentences or small paragraphs. At times, the author attempts to get philosophical with the neuroscience, which I found moot. I wish it read like a textbook because then it would be more structured and straightforward. The diagrams and scientific findings had poor quality and really small text, unlike a textbook. I found two-thirds of the book to be highly pragmatic and practical. The rest of the book is highly theoretical or philosophical.
Part I: Introduction & Background
These chapters were rich. Although the diagrams were poor in quality, I got a lot out of this section. The author did a great job in tying together all the structures in the basal ganglia, comparing and contrasting each structure (caudate, putamen, substantia niagra, etc.). Additionally, the author spends a lot of time piecing together the nuclei of the thalamus and their synaptic connections to the basal ganglia, cerebellum, and motor cortex.
The cell physiology was well written for every nucleus in the basal ganglia. The author discusses how these cells connect to other structures, their electrophysiological signature, and their role in modulating movement. Additionally, we understand the neurotransmitters involved with these structures. It was interesting to learn that the subthalamic nucleus is the only nucleus in the basal ganglia that is glutamatergic. The rest of the nuclei are inhibitory (GABA). Lastly, every major structure in the basal ganglia is a simple one-layer network, composed of many projection neurons. Hence, there are no local, complex microcircuits as seen in the cortex and cerebellum.
Chapters 5 & 6 describe how to quantify slow and fast electrical behavior in neurons; local field potentials, and single unit activity, respectively. Additionally, we are provided with an overview of an introperative neurophysiological monitoring system. The author briefly mentions the basics of grounding, amplifiers, filtering, and the frequency domain.
Part II: Computational Physiology of the Healthy Basal Ganglia
Chapter 7 discusses the discharge patterns for all the major structures in the basal ganglia and how that relates to their physiology. The most scintillating nucleus to learn about was the Gpe and its "pausers" displayed from the recording system. The most interesting fact regarding this chapter is that the Gpe is the main output structure for the basal ganglia.
Chapters 9 & 10 discuss the box and arrow models (D1/D2) for the basal ganglia. I was already familiar with these models, but the author added more context. Additionally, the author added an anatomical update by incorporating the PPN (pedunculopontine nucleus) into the model. Fascinating. I had just recently learned about the heavy impact this nucleus plays, along with the substania niagra, for coordinating and executing gait.
Part III: Computational Physiology of Basal Ganglia Disorders & Their Therapy
Chapter 13 provides a shining light on movement disorders. More specifically, the author compares and contrasts the differences between extrapyramidal and pyramidal disorders. Extrapyramidal diseases come from the cerebellum and basal ganglia. Abnormal movements, changes in muscle tone, postural abnormalities, and tremor characterize these disorders. Furthermore, we can have hypokinetic or hyperkinetic disorders, although there is a fuzzy line between the two. As we progress further into the chapter, a broad overview of the pathophysiology of parkinson's is described.
Chapter 14 provides a brief overview of the impact that animal models have had on understanding Parkinson's disease. I really appreciated the author's ethical views and responsibilities regarding experimentation on live animals.
Chapters 15 & 16 provide further details regarding spiking patterns, LFPs, and beta oscillations.
Given my clinical background in DBS, chapters 18 & 19 were highly relevant to me.
Ch 18 was a highly comprehensive chapter regarding DBS. The author sprinkles fruitful aspects of the DBS procedure, microelectrode recording, programming, stereotaxy, but most importantly, the hypothesized mechanisms for DBS.
The author stipulates that DBS acts as an "information lesion". Lesioning for DBS procedures (ablation) was more often performed in the past, but they were effective. The lesion is clearly having an impact on a node, similar to an open circuit. Hence, the pathological information is blocked. With DBS, injecting current into the area has a clear effect on the symptoms, but we don't know why. Popular theory among neurology, neurosurgery, and medical device representatives states that the stimulation is activating the basal ganglia. Due to the lack of dopamine, there is less activation in these areas. However, the author discusses synaptic depletion. Brilliant. Furthermore, you can only stimulate a neuron so many times before its intracellular vesicles, which house the neurotransmitters, are completely depleted. Once there are no more vesicles, it has no means to communicate with the neighboring synapse. DBS is causing synaptic failure, which has a functional inactivation effect similar to ablation therapy. However, according to the author, the stimulation rate has to be above 80 hertz for the information lesion to take effect. In conclusion, "stimulation" is misleading, at least as it relates to the mechanism of DBS.
Ch19 centered around closed-loop DBS. The author advocates for closed-loop DBS while at the same time claiming, "Neurophysiology is still an art, and most importantly, it does not pretend to be perfect”. It makes no sense advocating for closed loop while the electrophysiology is highly suspect and too theoretical for clinical application. According to the author, as it relates to the spectrum of LFPs that act as biomarkers for Parkinson's disease, "Even the phase-specific approach is naive because it divides the brain waves into two classes, good and bad, and assumes that all Parkinson's disease symptoms are the same". I would have to agree. Lastly, the beta band is only clinically useful for rigidity. This assumes you are even able to obtain a high-quality recording. I will end this note by stating that low beta is "likely associated" with akinetic rigid symptoms and that high beta is "potentially associated" with akinetic rigid symptoms. These are statements taken away from Medtronic's IFU for their brain-sensing platform.